tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kyle Rose, 221 are a BUY (84.35%), 40 are a HOLD (15.27%), 1 are a SELL (0.38%).
Analyst Kyle Rose, carries an average stock price target met ratio of 56.11% that have a potential upside of 25.63% achieved within 260 days. Previously, Kyle Rose worked at CANACCORD.
Kyle Rose’s has documented 511 price targets and ratings displayed on 32 stocks. The coverage was on Healthcare, Technology, Consumer Cyclical, Financial Services sectors.
Most recent stock forecast was given on SYK, Stryker at 18-Sep-2026.
Analyst best performing recommendations are on SGMS (SCIENTIFIC GAMES).
The best stock recommendation documented was for XENT (INTERSECT ENT) at 1/11/2021. The price target of $25 was fulfilled within 2 days with a profit of $2.78 (12.51%) receiving and performance score of 62.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2026
$16
$5.33 (49.95%)
$15
2 months 5 days ago
(05-Aug-2026)
0/2 (0%)
$6.43 (67.19%)
Buy Since 19-Oct-2020
$13
$2.33 (21.84%)
$11
2 months 5 days ago
(05-Aug-2026)
6/10 (60%)
$3.43 (35.84%)
255
Buy Since 01-Aug-2024
$12
$1.33 (12.46%)
$11
2 months 5 days ago
(05-Aug-2026)
2/4 (50%)
$2.43 (25.39%)
234
Buy Since 09-Mar-2026
$13
$2.33 (21.84%)
$16
3 months 2 days ago
(08-Jul-2026)
1/5 (20%)
$3.79 (41.15%)
13
Buy Since 19-Nov-2024
$24
$14.7 (158.06%)
$27
5 months 3 days ago
(07-May-2026)
3/6 (50%)
$16.25 (209.68%)
259
Which stock is Kyle Rose most bullish on?
Which stock is Kyle Rose most reserved on?
